Research menu
Jump to menu

Publications:  Dr Olivier Marches

Brooke MA, Etheridge SL, Kaplan N, Simpson C, O'Toole EA, Ishida-Yamamoto A, Marches O, Getsios S et al.(2014). iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function. Hum Mol Genet vol. 23, (15) 4064-4076.
Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TWF, Mansell A et al.(2013). A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature vol. 501, (7466) 247-251.
Simpson C, Brooke M, Marches O, Kelsell D (2013). A specific requirement for a disintegrin and metalloprotease (ADAM) 17 in protection against cutaneous Staphylococcus aureus infection. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 133, S192-S192.
Simpson C, Kelsell DP, Marchès O(2013). Connexin 26 facilitates gastrointestinal bacterial infection in vitro. Cell Tissue Res vol. 351, (1) 107-116.
Vossenkämper A, Macdonald TT, Marchès O(2011). Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system. J Inflamm (Lond) vol. 8,
Pearson JS, Riedmaier P, Marchès O, Frankel G, Hartland EL(2011). A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation. Mol Microbiol vol. 80, (1) 219-230.
Arbeloa A, Oates CV, Marchès O, Hartland EL, Frankel G(2011). Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells. Infect Immun vol. 79, (3) 1067-1076.
Vossenkämper A, Marchès O, Fairclough PD, Warnes G, Stagg AJ, Lindsay JO, Evans PC, Luong LA et al.(2010). Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J Immunol vol. 185, (7) 4118-4127.
Munera D, Crepin VF, Marches O, Frankel G(2010). N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins. J Bacteriol vol. 192, (13) 3534-3539.
Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G(2010). NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A vol. 107, (7) 3129-3134.
Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD et al.(2008). Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun vol. 76, (11) 4804-4813.
Marchès O, Covarelli V, Dahan S, Cougoule C, Bhatta P, Frankel G, Caron E(2008). EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell Microbiol vol. 10, (5) 1104-1115.
Bai L, Schüller S, Whale A, Mousnier A, Marches O, Wang L, Ooka T, Heuschkel R et al.(2008). Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2. Infect Immun vol. 76, (1) 361-368.
Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, Younis R, Matthews S et al.(2006). An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A vol. 103, (40) 14941-14946.
Vlisidou I, Marchés O, Dziva F, Mundy R, Frankel G, Stevens MP(2006). Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7. FEMS Microbiol Lett vol. 263, (1) 32-40.
Marchès O, Batchelor M, Shaw RK, Patel A, Cummings N, Nagai T, Sasakawa C, Carlsson SR et al.(2006). EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J Bacteriol vol. 188, (8) 3110-3115.
Kelly M, Hart E, Mundy R, Marches O, Wiles S, Badea L, Luck S, Tauschek M et al.(2006). Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. INFECT IMMUN vol. 74, (4) 2328-2337.
Marchés O, Wiles S, Dziva F, La Ragione RM, Schüller S, Best A, Phillips AD, Hartland EL et al.(2005). Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun vol. 73, (12) 8411-8417.
Garmendia J, Phillips AD, Carlier M-F, Chong Y, Schüller S, Marches O, Dahan S, Oswald E et al.(2004). TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol vol. 6, (12) 1167-1183.
Marchès O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F, Mainil J, Rosenshine I et al.(2003). Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol vol. 50, (5) 1553-1567.
Boullier S, Nougayrède J-P, Marchès O, Tasca C, Boury M, Oswald E, De Rycke J, Milon A(2003). Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. Microbes Infect vol. 5, (10) 857-867.
Beutin L, Marchés O, Bettelheim KA, Gleier K, Zimmermann S, Schmidt H, Oswald E(2003). HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia. Infect Immun vol. 71, (7) 3995-4002.
Stevens MP, Marchès O, Campbell J, Huter V, Frankel G, Phillips AD, Oswald E, Wallis TS(2002). Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops. Infect Immun vol. 70, (2) 945-952.
Nougayrède JP, Boury M, Tasca C, Marchès O, Milon A, Oswald E, De Rycke J(2001). Type III secretion-dependent cell cycle block caused in HeLa cells by enteropathogenic Escherichia coli O103. Infect Immun vol. 69, (11) 6785-6795.
Return to top